Psychomotor Disorders

Abstract

Psychomotor disorders are disturbances of the link between mental activity and movement, in which the speed, quantity, and control of motor behaviour change with a person's psychological state rather than from damage to the motor apparatus itself. They span a continuum from the slowed movement, speech, and reaction time of psychomotor retardation, through the driven, purposeless overactivity of psychomotor agitation, to the profound motor dysregulation of catatonia, and they are among the oldest recognised signs in clinical psychiatry. This article defines the psychomotor domain, sets out its principal types, examines retardation in depression, agitation, catatonia, and the motor abnormalities of schizophrenia, and reviews how the domain is measured, with interactive demonstrations. MeSH classifies psychomotor disorders among the neurobehavioral manifestations.

Keywords: psychomotor disorders, psychomotor retardation, psychomotor agitation, catatonia

What Psychomotor Disorders Are

A psychomotor disorder is a disturbance of motor behaviour that arises from, and varies with, a person's mental state, rather than from a primary lesion of the muscles, nerves, or basic motor pathways. The term joins the psychological and the motor on purpose: what changes is not the capacity to move but the way movement is organised, initiated, and paced as an expression of mood, drive, and thought. A severely depressed patient may sit motionless for hours, speak slowly and sparely, and take many seconds to answer a simple question; an agitated patient may pace, wring the hands, and be unable to sit still; a patient with catatonia may hold a fixed posture, resist passive movement, or fall mute. In each case the abnormality is of the person's whole motor output in relation to their inner state, and it moves as that state moves.

The idea is old. Nineteenth-century psychiatry, and Karl Kahlbaum's description of catatonia in particular, treated disordered movement as a direct window onto disordered mind, and the psychomotor signs of melancholia and mania were among the first features used to tell the major syndromes apart (Hirjak et al., 2020). Psychomotor change remains a core diagnostic criterion for a major depressive episode and a defining feature of catatonia, and it is one of the few psychiatric signs that an observer can watch directly rather than infer from report (Sobin & Sackeim, 1997). That observability is also what makes the domain attractive to cognitive science: psychomotor speed and activity can be timed, counted, and instrumented, turning a clinical impression into a measurable quantity.

The domain is most usefully organised along a single axis of psychomotor activity, with retardation at the low end and agitation at the high end, and with catatonia as a severe disturbance that can sit at either extreme. Table 1 sets out the three principal presentations, the conditions in which each is most prominent, and the characteristic signs; the sections that follow take them in turn.

Types of Psychomotor Disorders

In the Medical Subject Headings vocabulary, Psychomotor Disorders is a descriptor within the neurobehavioral manifestations, and it has two narrower descriptors directly beneath it that carry their own articles on this site. These narrower terms are not a taxonomy of the whole domain so much as the two subcategories the indexing vocabulary singles out, and they are orthogonal rather than exclusive: a disorder may involve apraxia, agitation, both, or neither of the indexed children while still being a psychomotor disturbance. MeSH is an indexing classification built to retrieve the literature, not a theory of how the disorders relate, so the division below is a map of the library shelves, not of the mind. Table 2 lists the narrower descriptors, each glossed from its MeSH scope and linked to its article.

Psychomotor Retardation

Psychomotor retardation is a generalised slowing of movement, speech, and thought, and it is the most thoroughly studied psychomotor disturbance because of its central place in melancholic depression. The slowed patient moves less and more slowly, initiates action with difficulty, speaks quietly and with long pauses, shows reduced gesture and a flattened face, and takes an abnormally long time to respond to questions or to begin a task (Sobin & Sackeim, 1997). Clinically it is more than a loose impression of sluggishness: systematic review establishes retardation as a core, diagnostically useful feature that distinguishes melancholic depression from other forms and tracks the severity and the response to treatment (Bennabi et al., 2013).

A central finding of the instrumental work is that retardation has separable components. Caligiuri and Ellwanger used movement-analysis methods to dissociate the motor aspect of slowing, the time taken to execute a movement once begun, from the cognitive aspect, the time taken to process information and decide, and showed that both are affected but to different degrees across patients (Caligiuri & Ellwanger, 2000). Fine-motor measures sharpen the picture further: Pier and colleagues found that fine-motor slowing specifically distinguishes melancholic from non-melancholic depression, supporting psychomotor change as a subtype marker rather than a non-specific accompaniment of low mood (Pier et al., 2004). Reviews of the broader literature treat these objectively measurable fine-motor and reaction-time changes as a diagnostic, pathophysiological, and therapeutic tool (Schrijvers et al., 2008).

The construct and its measurement owe much to Daniel Widlöcher, who built the first dedicated quantitative instrument for retardation, the Salpêtrière Retardation Rating Scale, and to the synthesis of its biological underpinnings, measurement, and treatment that followed (Buyukdura et al., 2011). Gordon Parker pressed the stronger claim that melancholia is fundamentally a disorder of psychomotor function, not merely a disorder of mood with motor accompaniments, and built the sign-based CORE measure to capture it (Parker & Hadzi-Pavlovic, 1996).

Psychomotor Agitation

Psychomotor agitation is the high-activity counterpart of retardation: a state of driven, purposeless motor overactivity that accompanies inner tension. The agitated person cannot sit still, paces, wrings or rubs the hands, picks at clothing or skin, and shifts position constantly, and the activity is non-productive, serving no goal beyond the discharge of restlessness (Sobin & Sackeim, 1997). It appears in agitated depression, in mania, and in delirium, and in depression it can coexist with retardation in the same patient, so that slowed movement and restless overactivity alternate rather than excluding one another.

The construct is harder to pin down than retardation, and this has hampered its study. Day argued that psychomotor agitation is poorly defined and badly measured, with the term covering a heterogeneous mix of behaviours and few instruments able to quantify it reliably, and called for operational criteria that separate genuine agitation from superficially similar states (Day, 1999). The most important differential is akathisia, the drug-induced inner restlessness and urge to move produced by antipsychotic and some antidepressant medication; Sachdev and Kruk characterised its clinical features and predisposing factors, and distinguishing it from the agitation of the underlying illness is a recurring clinical problem, because the two call for opposite changes in medication (Sachdev & Kruk, 1994).

Catatonia

Catatonia is the most severe psychomotor syndrome, a profound dysregulation of movement and behaviour that can present as extreme immobility or as extreme excitement, often alternating between the two. Its signs include mutism, immobility or stupor, posturing and the maintenance of bizarre positions, rigidity, waxy flexibility in which a limb placed by an examiner is held, negativism or motiveless resistance, echophenomena, and at the other pole an agitated, purposeless excitement (Walther et al., 2019). Diagnostically the syndrome is defined not by any single sign but by their number: current criteria require at least three of twelve such signs to be present, so it is the count rather than any one feature that marks catatonia (American Psychiatric Association, 2013). Once considered a subtype of schizophrenia, catatonia is now recognised across mood disorders, schizophrenia, and a wide range of medical and neurological illness, and it is a treatable condition that responds to benzodiazepines and electroconvulsive therapy (Hirjak et al., 2024).

Catatonia has become a theoretical testing ground for how the brain links mind and movement. Georg Northoff proposed that catatonia reflects a disturbance of top-down cortical modulation, in which prefrontal regions fail to regulate motor and emotional output, tying the motor signs to a failure of higher control rather than to the basal-ganglia pathways of ordinary movement disorders (Northoff, 2002). Returning to Kahlbaum's original psychomotor conception, Hirjak and colleagues argued that catatonia is more than a motor and dopaminergic syndrome, pointing to GABAergic and sensorimotor mechanisms and to the subjective experience that accompanies the motor signs (Hirjak et al., 2020). A spatiotemporal account developed by Northoff and Hirjak links that subjective experience directly to the motor abnormalities, treating catatonia as a disorder of how the brain structures experience in time rather than of movement alone (Northoff & Hirjak, 2024).

Motor Abnormalities in Schizophrenia

Beyond catatonia, schizophrenia is accompanied by a broad spectrum of motor abnormalities that are increasingly understood as intrinsic to the illness rather than as side effects of treatment. Walther and Strik set out this spectrum, which includes psychomotor slowing, catatonic signs, spontaneous dyskinesia, and neurological soft signs, and argued that these motor features are a core dimension of schizophrenia present even in never-medicated patients (Walther & Strik, 2012). Hirjak and colleagues made the case for treating motor dysfunction as a distinct, measurable dimension of the schizophrenia spectrum, an underappreciated domain alongside the positive, negative, and cognitive dimensions (Hirjak et al., 2015).

The practical payoff of this reframing is the search for objective markers. Osborne and colleagues positioned psychomotor slowing as a candidate endophenotype and biomarker for psychosis, reviewing how it can be measured and its neural correlates, on the argument that an objectively timed motor sign may index the underlying pathology more reliably than a symptom rating (Osborne et al., 2020). Realising that promise requires standard measurement, which is why a European consensus set out how the motor and sensorimotor abnormalities of psychosis should be assessed, bringing order to a field that had used many incompatible instruments (Walther et al., 2020).

Measurement and Assessment

What unites the psychomotor domain and gives it its scientific value is that its features can be measured objectively. Assessment runs from clinician-rated sign-based scales to fully instrumented timing. On the clinical side, the Salpêtrière Retardation Rating Scale and the sign-based CORE measure quantify retardation from observed behaviour, and the Bush-Francis Catatonia Rating Scale, introduced to standardise the catatonia examination, counts catatonic signs against defined criteria (Bush et al., 1996; Buyukdura et al., 2011; Parker & Hadzi-Pavlovic, 1996; Hirjak et al., 2024). On the instrumental side, reaction-time tasks, fine-motor kinematics, actigraphy, and gait analysis turn slowing and overactivity into numbers, and these methods are what allowed the motor and cognitive components of retardation to be dissociated in the first place (Caligiuri & Ellwanger, 2000; Schrijvers et al., 2008).

The recurring obstacle is standardisation. Because psychomotor agitation in particular has been defined and measured inconsistently, estimates of its frequency and its response to treatment are hard to compare across studies (Day, 1999). The consensus efforts in psychosis are a direct response, agreeing on which domains to assess and with which instruments so that findings can be pooled and a motor sign can serve as a shared biomarker rather than a local one (Walther et al., 2020; Osborne et al., 2020).

Figure

Figure 1

The Psychomotor Activity Continuum

Interactive Demonstrations

The three demonstrations below make the core ideas manipulable. The first lets the reader move along the psychomotor activity continuum and see the clinical picture that each level produces. The second decomposes a timed response into its cognitive and motor components, the dissociation at the heart of the instrumental study of retardation. The third is a sign-counting catatonia screen that shows how a threshold of signs, rather than any one sign, defines the syndrome.

Worked Example

Consider the instrumental logic that lets psychomotor retardation be split into a cognitive and a motor part, the dissociation Caligiuri and Ellwanger established. A timed response task separates two intervals: the initiation time, from the signal to the start of movement, which reflects the cognitive work of processing and deciding, and the movement time, from the start of movement to its completion, which reflects motor execution. The total response time is their sum.

Take a healthy baseline of an initiation time of 250 milliseconds and a movement time of 150 milliseconds, for a total of 400 milliseconds. In a retarded patient both intervals lengthen, say to an initiation time of 450 milliseconds and a movement time of 300 milliseconds, for a total of 750 milliseconds. The total response is slower by 350 milliseconds, an increase of 87.5 percent over baseline. Decomposing that excess, the initiation time has grown by 200 milliseconds and the movement time by 150 milliseconds, so the cognitive component accounts for 200 of the 350 milliseconds of added delay, about 57 percent, and the motor component for the remaining 150 milliseconds, about 43 percent.

The worked lesson is that a single observed slowing of nearly ninety percent is not one thing but two, and that an instrument which times the components separately can say how much of a given patient's retardation is cognitive and how much is motor. That is exactly the dissociation that turns retardation from a clinical impression into a measurable, decomposable quantity, and the same split underlies the finding that fine-motor slowing specifically marks melancholic depression (Caligiuri & Ellwanger, 2000; Pier et al., 2004).

Discussion

Psychomotor disorders occupy an unusual position in psychiatry because they are at once among the most subjective in origin and the most objective in measurement. The abnormality springs from mood, drive, and thought, yet it shows itself in movement that can be timed, counted, and instrumented, which is why the domain has become a bridge between the clinical description of mental illness and the quantitative methods of cognitive and motor neuroscience. The dissociation of retardation into cognitive and motor components, the search for psychomotor slowing as an endophenotype of psychosis, and the reframing of catatonia as a disorder of top-down modulation all depend on taking a classical psychiatric sign and submitting it to measurement.

The unifying theme across depression, schizophrenia, and catatonia is that motor output is not a passive readout of a separate motor system but an integral expression of the state of the mind that drives it. Retardation and agitation are the low and high excursions of a single activity dimension; catatonia is its most severe breakdown; and the motor abnormalities of schizophrenia are an intrinsic dimension of the illness rather than a treatment artefact. The open problems are those of integration and standardisation: agreeing on how to measure each feature so that findings can be pooled, and building accounts, like the top-down and spatiotemporal models of catatonia, that explain why a disturbance of mind should express itself so directly in movement.

Current Directions

The most active front is the drive to turn psychomotor signs into standardised, objective markers of brain state. The European consensus on assessing the motor and sensorimotor abnormalities of psychosis is an attempt to make measurement comparable across centres, a precondition for using a motor sign as a biomarker rather than a local observation (Walther et al., 2020). In parallel, psychomotor slowing is being evaluated as a candidate endophenotype whose objective timing may index pathology more reliably than symptom ratings do (Osborne et al., 2020).

For catatonia, the direction of travel is away from a purely motor and dopaminergic picture toward an account that includes GABAergic and sensorimotor mechanisms and the subjective experience that accompanies the signs, and the current authoritative Primer consolidates this broadened view of its mechanisms, assessment, and treatment (Hirjak et al., 2024; Hirjak et al., 2020). The spatiotemporal programme goes further, seeking a single framework in which the way the brain structures experience in time explains both the subjective and the motor sides of the disorder, which would tie the psychomotor domain to a general theory of how mind and movement are organised together (Northoff & Hirjak, 2024).

Common Misconceptions

Psychomotor retardation just means the patient is tired or unmotivated.

Retardation is an objectively measurable slowing of movement and processing with separable motor and cognitive components, not a matter of effort or motivation; instrumented timing dissociates its parts and distinguishes melancholic depression from other forms (Caligiuri & Ellwanger, 2000; Bennabi et al., 2013).

The restlessness of agitation is the same as drug-induced akathisia.

Akathisia is a medication-induced motor restlessness with its own clinical features and predisposing factors, and distinguishing it from the agitation of the underlying illness matters because the two call for opposite changes in treatment (Sachdev & Kruk, 1994; Day, 1999).

Catatonia is a subtype of schizophrenia.

Catatonia occurs across mood disorders, schizophrenia, and medical illness, and is a distinct, treatable syndrome rather than a schizophrenia subtype (Walther et al., 2019; Hirjak et al., 2024).

The motor abnormalities of schizophrenia are only medication side effects.

A spectrum of motor signs is present in never-medicated patients and is now treated as an intrinsic dimension of the illness, distinct from drug-induced movement disorders (Walther & Strik, 2012; Hirjak et al., 2015).

Glossary

Key Researchers

Dusan Hirjak

(Central Institute of Mental Health, Mannheim). Reframed catatonia and schizophrenia-spectrum motor dysfunction as a distinct sensorimotor domain, returning to Kahlbaum's psychomotor origins. Faculty · Google Scholar · Wikidata

Georg Northoff

(Institute of Mental Health Research, University of Ottawa). Proposed the top-down modulation hypothesis of catatonia and the spatiotemporal-psychopathology framework linking subjective experience to psychomotor signs. Faculty · Google Scholar · Wikipedia · Wikidata

Gordon Parker

(University of New South Wales; Black Dog Institute). Reframed melancholia as fundamentally a disorder of psychomotor function and built the sign-based CORE measure of psychomotor disturbance. ORCID · Google Scholar · Faculty · Wikipedia

Harold A. Sackeim

(Columbia University; New York State Psychiatric Institute). Co-author of the landmark review of the psychomotor symptoms of depression and their measurement, and a pioneer of electroconvulsive therapy research. Google Scholar · Wikipedia · Wikidata

Sebastian Walther

(University Hospital of Psychiatry, University of Bern). Leading authority on the motor and psychomotor abnormalities of schizophrenia and catatonia, and led the European consensus on their assessment. ORCID · Google Scholar · Faculty

Daniel Widlöcher

(Pitié-Salpêtrière Hospital; Université Paris VI). Pioneer of the systematic study of psychomotor retardation and author of the Salpêtrière Retardation Rating Scale, the first dedicated quantitative measure of the construct. Wikipedia · Wikidata

Frequently Asked Questions

What are psychomotor disorders?

They are disturbances of movement that arise from and vary with a person's mental state rather than from damage to the muscles or motor pathways. The speed, amount, and control of motor behaviour change as an expression of mood, drive, and thought.

What is psychomotor retardation?

It is a generalised slowing of movement, speech, and thought, a core feature of melancholic depression. The slowed person moves and speaks slowly, takes a long time to respond, and shows reduced gesture and facial expression.

What is psychomotor agitation?

It is driven, purposeless motor overactivity that accompanies inner tension, such as pacing, hand-wringing, and an inability to sit still. It appears in agitated depression, mania, and delirium.

How are retardation and agitation related?

They are the low and high ends of a single continuum of psychomotor activity, with a normal range in between. In depression the two can coexist, so that slowed movement and restless overactivity alternate in the same patient.

What is catatonia?

Catatonia is the most severe psychomotor syndrome, marked by immobility or excitement, mutism, posturing, rigidity, waxy flexibility, and negativism. It occurs across mood disorders, schizophrenia, and medical illness, and it responds to benzodiazepines and electroconvulsive therapy.

How is psychomotor disturbance measured?

By sign-based clinical scales such as the Salpêtrière Retardation Rating Scale, the CORE measure, and the Bush-Francis Catatonia Rating Scale, and by instrumented methods such as reaction-time tasks, fine-motor kinematics, and actigraphy that time movement objectively.

Is the restlessness of agitation the same as akathisia?

No. Akathisia is a medication-induced motor restlessness with its own features, and it must be distinguished from the agitation of the underlying illness because the two call for opposite changes in treatment.

Why do psychomotor disorders matter for cognitive science?

Because they turn a subjective mental state into movement that can be timed and counted, they let the link between mind and motor output be measured directly, yielding objective markers and testing theories of how higher control shapes action.

References

American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing. https://doi.org/10.1176/appi.books.9780890425596

Bennabi, D., Vandel, P., Papaxanthis, C., Pozzo, T., & Haffen, E. (2013). Psychomotor retardation in depression: A systematic review of diagnostic, pathophysiologic, and therapeutic implications. BioMed Research International, 2013, 158746. https://doi.org/10.1155/2013/158746

Bush, G., Fink, M., Petrides, G., Dowling, F., & Francis, A. (1996). Catatonia. I. Rating scale and standardized examination. Acta Psychiatrica Scandinavica, 93(2), 129–136. https://doi.org/10.1111/j.1600-0447.1996.tb09814.x

Buyukdura, J. S., McClintock, S. M., & Croarkin, P. E. (2011). Psychomotor retardation in depression: Biological underpinnings, measurement, and treatment. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 35(2), 395–409. https://doi.org/10.1016/j.pnpbp.2010.10.019

Caligiuri, M. P., & Ellwanger, J. (2000). Motor and cognitive aspects of motor retardation in depression. Journal of Affective Disorders, 57(1–3), 83–93. https://doi.org/10.1016/S0165-0327(99)00068-3

Day, R. K. (1999). Psychomotor agitation: Poorly defined and badly measured. Journal of Affective Disorders, 55(2–3), 89–98. https://doi.org/10.1016/S0165-0327(99)00010-5

Hirjak, D., Thomann, P. A., Kubera, K. M., Wolf, N. D., Sambataro, F., & Wolf, R. C. (2015). Motor dysfunction within the schizophrenia-spectrum: A dimensional step towards an underappreciated domain. Schizophrenia Research, 169(1–3), 217–233. https://doi.org/10.1016/j.schres.2015.10.022

Hirjak, D., Kubera, K. M., Wolf, R. C., & Northoff, G. (2020). Going back to Kahlbaum's psychomotor (and GABAergic) origins: Is catatonia more than just a motor and dopaminergic syndrome? Schizophrenia Bulletin, 46(2), 272–285. https://doi.org/10.1093/schbul/sbz074

Hirjak, D., Rogers, J. P., Wolf, R. C., Kubera, K. M., Fritze, S., Wilson, J. E., Sambataro, F., Fricchione, G., Meyer-Lindenberg, A., Ungvari, G. S., & Northoff, G. (2024). Catatonia. Nature Reviews Disease Primers, 10(1), 49. https://doi.org/10.1038/s41572-024-00534-w

Northoff, G. (2002). What catatonia can tell us about “top-down modulation”: A neuropsychiatric hypothesis. Behavioral and Brain Sciences, 25(5), 555–604. https://doi.org/10.1017/s0140525x02000109

Northoff, G., & Hirjak, D. (2024). Spatiotemporal psychopathology – An integrated brain-mind approach and catatonia. Schizophrenia Research, 263, 151–159. https://doi.org/10.1016/j.schres.2022.10.006

Osborne, K. J., Walther, S., Shankman, S. A., & Mittal, V. A. (2020). Psychomotor slowing in schizophrenia: Implications for endophenotype and biomarker development. Biomarkers in Neuropsychiatry, 2, 100016. https://doi.org/10.1016/j.bionps.2020.100016

Parker, G., & Hadzi-Pavlovic, D. (Eds.). (1996). Melancholia: A disorder of movement and mood: A phenomenological and neurobiological review. Cambridge University Press. ISBN 9780521472753.

Pier, M. P. B. I., Hulstijn, W., & Sabbe, B. G. C. (2004). Differential patterns of psychomotor functioning in unmedicated melancholic and nonmelancholic depressed patients. Journal of Psychiatric Research, 38(4), 425–435. https://doi.org/10.1016/j.jpsychires.2003.11.008

Sachdev, P., & Kruk, J. (1994). Clinical characteristics and predisposing factors in acute drug-induced akathisia. Archives of General Psychiatry, 51(12), 963–974. https://doi.org/10.1001/archpsyc.1994.03950120035007

Schrijvers, D., Hulstijn, W., & Sabbe, B. G. C. (2008). Psychomotor symptoms in depression: A diagnostic, pathophysiological and therapeutic tool. Journal of Affective Disorders, 109(1–2), 1–20. https://doi.org/10.1016/j.jad.2007.10.019

Sobin, C., & Sackeim, H. A. (1997). Psychomotor symptoms of depression. American Journal of Psychiatry, 154(1), 4–17. https://doi.org/10.1176/ajp.154.1.4

Walther, S., & Strik, W. (2012). Motor symptoms and schizophrenia. Neuropsychobiology, 66(2), 77–92. https://doi.org/10.1159/000339456

Walther, S., Stegmayer, K., Wilson, J. E., & Heckers, S. (2019). Structure and neural mechanisms of catatonia. The Lancet Psychiatry, 6(7), 610–619. https://doi.org/10.1016/S2215-0366(18)30474-7

Walther, S., van Harten, P. N., Waddington, J. L., Cuesta, M. J., Peralta, V., Dupin, L., Foucher, J. R., Sambataro, F., Morrens, M., Kubera, K. M., Pieters, L. E., Stegmayer, K., Strik, W., Wolf, R. C., & Hirjak, D. (2020). Movement disorder and sensorimotor abnormalities in schizophrenia and other psychoses – European consensus on assessment and perspectives. European Neuropsychopharmacology, 38, 25–39. https://doi.org/10.1016/j.euroneuro.2020.07.003